Date: April 21-24, 2020
Location: Boston, MA, USA
The Translational Microbiome Conference will bring together the leading microbiome companies working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies, and direct-to-consumer services and products across a range of therapeutic areas, from gut to skin and beyond. Entering its 6th year in 2020, the meeting will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. With a broad focus spanning multiple disease states (oncology, dermatology, inflammatory disorders, among others) attendees will have the opportunity to hear the leading companies discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes.
Don't miss the session by Charles R. Budinoff, Ph.D., Strain Discovery and Microbiome Science Leader, DuPont Nutrition & Biosciences on April 21, 1:15 pm. Charles will be presenting on "A Microbiome Platform for the Development of Personalized Nutrition and Therapeutics".
Register your interest here: https://www.microbiomeconference.com/